Society guideline links: Migraine and other primary headache disorders

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Adult with headache in the emergency department".)

International

●European Academy of Neurology (EAN) and World Health Organization (WHO): Guideline on trigeminal neuralgia (2019)

●European Headache Federation (EHF) and WHO: Consensus article on aids to management of headache disorders in primary care, 2nd edition (2019)

●International Headache Society (IHS): International classification of headache disorders, 3rd edition (2018)

Canada

●Choosing Wisely Canada: Canadian Headache Society (CHS) – Four tests and treatments to question (2020)

●CHS: Guideline on acute drug therapy for migraine headache (2013)

●CHS: Guideline for migraine prophylaxis (2012)

United States

●American Academy of Neurology (AAN): Practice guideline on botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache, update (2016, reaffirmed 2019)

●AAN and American Headache Society (AHS): Practice guideline – Acute treatment of migraine in children and adolescents, update (2019)

●AAN and AHS: Practice guideline – Pharmacologic treatment for pediatric migraine prevention, update (2019)

●AAN and Child Neurology Society (CNS): Practice parameter – Evaluation of children and adolescents with recurrent headaches (2002, reaffirmed 2019)

●AHS: Position statement on integrating new migraine treatments into clinical practice (2019)

●American College of Radiology (ACR): ACR Appropriateness Criteria on headache (2017)

●ACR: ACR Appropriateness Criteria on headache – Child (2017)

●Choosing Wisely: Don't do imaging for uncomplicated headaches (2012, updated 2017)

●AHS: Evidence-based guidelines for treatment of cluster headache (2016)

●AAN and AHS: Evidence-based guideline – Pharmacologic treatment for episodic migraine prevention in adults, update (2012, reaffirmed 2015)

●Choosing Wisely: AHS – Five things physicians and patients should question (2013)

●Choosing Wisely: Don't perform electroencephalography (EEG) for headaches (2013)

●Choosing Wisely: Don't use opioid or butalbital treatment for migraine except as a last resort (2013)

●AAN: Acute and preventive pharmacologic treatment of cluster headache (2010)

●American College of Emergency Physicians (ACEP): Clinical policy – Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache (2008)

Europe

●European Academy of Neurology (EAN) and World Health Organization (WHO): Guideline on trigeminal neuralgia (2019)

●European Headache Federation (EHF) and WHO: Consensus article on aids to management of headache disorders in primary care, 2nd edition (2019)

●EHF: Guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention (2019)

●European Medicines Agency (EMA) and EHF: Overview of the latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age (2018)

●EHF: Consensus on technical investigation for primary headache disorders (2016)

●EHF: Position statement on neuromodulation of chronic headaches (2013)

●European Federation of the Neurological Societies (EFNS): Guidelines on neurophysiological tests and neuroimaging procedures in non-acute headache, 2nd edition (2011)

●EFNS: Guideline on treatment of medication overuse headache (2011)

●EFNS: Guidelines on treatment of miscellaneous idiopathic headache disorders (Group 4 of the IHS classification) (2011)

●EFNS: Guideline on the treatment of tension-type headache (2010)

●EFNS: Guideline on the drug treatment of migraine (2009)

●EFNS: Guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias (2006)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine (2022)

●NICE: Clinical guideline on headaches in over 12s – Diagnosis and management (2012, updated 2021)

●NICE: Medical technologies guidance on gammaCore for cluster headache (2019)

●Choosing Wisely UK: Royal College of Physicians (RCP) – Patients with suspected migraine mostly don't need brain imaging (2018)

●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline for the pharmacological management of migraine (2018)

●NICE: Interventional procedures guidance for transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine (2016)

●NICE: Interventional procedures guidance for implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache (2015)

●NICE: Interventional procedures guidance for transcranial magnetic stimulation for treating and preventing migraine (2014)

●NICE: Interventional procedures guidance on occipital nerve stimulation for intractable chronic migraine (2013)

●NICE: Quality standard on headaches in over 12s (2013)

●RCP: Clinical guideline on diagnosis and management of headaches in young people and adults (2012)

●Royal College of General Practitioners (RCGP) and British Association for the Study of Headache (BASH): Guidance for the management of headache in sport (2011)

●BASH: Guidelines for all healthcare professionals in the diagnosis and management of migraine/tension-type headache/cluster headache/medication-overuse headache, 3rd edition (2010)

●NICE: Interventional procedures guidance for percutaneous closure of patent foramen ovale for recurrent migraine (2010)

Australia-New Zealand

●Choosing Wisely Australia: Don't perform imaging of the brain for non-acute primary headache disorders (2016)

●Choosing Wisely Australia: Don't use opioids for the treatment of migraine, except in rare circumstances (2016)

Japan

●[In English] Japanese Society of Neurology (JSN) and Japanese Headache Society (JHS): Clinical practice guideline for chronic headache (2013)

●[In Japanese] JSN and JHS: Clinical practice guideline for chronic headache (2013)